Market Place
Sourcing Support
PHAXIAM Reports Third-Quarter 2024 Financial Information
13 Nov 2024 //
GLOBENEWSWIRE
Monthly Voting Rights & Share Capital Information as of Oct 31
08 Nov 2024 //
GLOBENEWSWIRE
PHAXIAM Therapeutics Receives FDA Clearance for Phase II Study
04 Nov 2024 //
GLOBENEWSWIRE
Total Number of Voting Rights And Shares Update As Of Oct 8 2024
10 Oct 2024 //
GLOBENEWSWIRE
Phaxiam Announces New Phase 2 Investigator-Initiated Study
09 Oct 2024 //
GLOBENEWSWIRE
Phaxiam Provides H1 2024 Business And Financial Update
25 Sep 2024 //
GLOBENEWSWIRE
Monthly information related to voting rights and shares composing share capital
03 Jul 2024 //
GLOBENEWSWIRE
Results of the Combined General Meeting of 28 June 2024
28 Jun 2024 //
GLOBENEWSWIRE
PHAXIAM Avails Documents For June 28 General Meeting
07 Jun 2024 //
GLOBENEWSWIRE
Adial Pharma: First Patient Dosed In AD04 PK Study For AUD
05 Jun 2024 //
GLOBENEWSWIRE
PHAXIAM provides Business and Financial Update for the First Quarter of 2024
15 May 2024 //
GLOBENEWSWIRE
Novo Nordisk Share Capital Composition As Of April 30, 2024
03 May 2024 //
GLOBENEWSWIRE
PHAXIAM Enrolls First Patient In Staph Endocarditis Phase 1
15 Apr 2024 //
GLOBENEWSWIRE
Monthly update on total voting rights - March 29, 2024
09 Apr 2024 //
GLOBENEWSWIRE
Phaxiam announces filing of its 2023 Universal Registration Document
05 Apr 2024 //
GLOBENEWSWIRE
PHAXIAM announces effectiveness of delisting of American Depositary Shares
11 Mar 2024 //
GLOBENEWSWIRE
Monthly information related to total number of voting rights
05 Mar 2024 //
GLOBENEWSWIRE
PHAXIAM announces intention to voluntary delist American Depositary Shares
20 Feb 2024 //
GLOBENEWSWIRE
Monthly information related to total number of voting rights and shares
06 Feb 2024 //
GLOBENEWSWIRE
PHAXIAM Therapeutics announces its cash position at the end of 2023
18 Jan 2024 //
GLOBENEWSWIRE
Monthly information related to total number of voting rights
03 Jan 2024 //
GLOBENEWSWIRE
Monthly information related to total number of voting rights and shares
06 Dec 2023 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.